Drug Profile
YH 4808
Alternative Names: YH-4808Latest Information Update: 27 Aug 2019
Price :
$50
*
At a glance
- Originator Yuhan
- Class Antiulcers; Gastric antisecretories; Small molecules
- Mechanism of Action Potassium-competitive acid blockers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Gastro-oesophageal reflux; NSAID-induced ulcer; Reflux oesophagitis
Most Recent Events
- 27 Aug 2019 Discontinued - Phase-I for Gastro-oesophageal reflux (In volunteers) in USA (PO)
- 27 Aug 2019 Discontinued - Phase-II for Gastro-oesophageal reflux in South Korea (PO)
- 27 Aug 2019 Discontinued - Phase-II for Reflux oesophagitis in South Korea (PO)